GlassScriptPhysician profile
Robert A Clifford
NPI 1780659284
$7,615.81
in general payments reported to CMS, 2019-2025
26 companies · $109 in 2025
The $109 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $40.92 · 2021: $2,207 · 2022: $4,497 · 2023: $264 · 2024: $206 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563 · Long Term Medical Supply Or Device Loan: $15.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.89 |
| Long Term Medical Supply Or Device Loan | $15.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $6,348.30 | 2019-2025 | Bexsero |
| Tris Pharma INC | $257.81 | 2019-2025 | Dyanavel Xr, Quillivant |
| Ironshore Pharmaceuticals INC. | $214.22 | 2020-2023 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $195.05 | 2021-2024 | Qelbree, Qelbree |
| Baxter Healthcare | $149.82 | 2022-2024 | Hillrom - Spot Vision Screener |
| Pfizer INC. | $119.64 | 2019-2023 | |
| Seqirus USA INC | $58.86 | 2022-2025 | Flucelvax, Flucelvax Quadrivalent |
| Shire North American Group INC | $48.00 | 2019 | |
| Sanofi Pasteur INC. | $45.30 | 2023-2024 | |
| Corium, LLC | $43.21 | 2023 | Azstarys |
| Sobi, INC | $30.79 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $23.54 | 2024 | |
| Nestle Healthcare Nutrition INC. | $20.62 | 2023 | |
| Verrica Pharmaceuticals INC. | $17.54 | 2025 | Ycanth |
| Adlon Therapeutics L.P. | $16.50 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $14.92 | 2021 | |
| Vertical Pharmaceuticals, LLC | $11.69 | 2019 |
9 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Clifford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.